For Better User Experience Please Use Potrait Mode.

About OncoStem Diagnostics, Published in ET

THE ECONOMIC TIMES

October 30

"Today in India over 90% of breast cancer patients go for chemotherapy to avoid recurrence however if you are a stage 1 cancer patient you might not have to go through chemo, our test helps determine that crucial decision," Dr Manjiri Bakre, Founder of OncoStem told ET. The start up's CanAssist-Breast test, Bakre claims, costs one fifth of what similar tests cost in US and Europe with less turnaround time. Typical tumour diagnostic tests roughly cost $4000 or RS 2.8 lakhs in US, Bakre says.

Author:

Team OncoStem

Team OncoStem updates the latest information about the OncoStem Diagnostics and its products in news room. Subscribe us to get latest updates. For more/detailed information please write to us on info@oncostemdiagnostics.com or call us on +91- 96866 96505.